Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126010931 | 12601093 | 1 | I | 2015 | 20160129 | 20160728 | 20160728 | EXP | US-ROCHE-1704004 | ROCHE | 0.00 | F | Y | 68.10000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126010931 | 12601093 | 1 | PS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 103792 | SOLUTION FOR INFUSION | /wk | |||||||||
126010931 | 12601093 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 103792 | SOLUTION FOR INFUSION | Q3W | |||||||||
126010931 | 12601093 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | THE DAY AFTER ^TRIPLE COCKTAIL^ | U | 125031 | Q3W | ||||||||
126010931 | 12601093 | 4 | SS | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | Q3W | |||||||||
126010931 | 12601093 | 5 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | U | 0 | Q3W | |||||||||
126010931 | 12601093 | 6 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | TAKING FOR SEVERAL YEARS, 1TO 2 IN 1 DAY | 0 | 2 | MG | ||||||||
126010931 | 12601093 | 7 | C | ARIMIDEX | ANASTROZOLE | 1 | Oral | 0 | QD | ||||||||||
126010931 | 12601093 | 8 | C | LOMOTIL (UNITED STATES) | 2 | Oral | 0 | ||||||||||||
126010931 | 12601093 | 9 | C | PROLIA | DENOSUMAB | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126010931 | 12601093 | 1 | Breast cancer |
126010931 | 12601093 | 3 | Product used for unknown indication |
126010931 | 12601093 | 4 | Breast cancer |
126010931 | 12601093 | 5 | Breast cancer |
126010931 | 12601093 | 6 | Restless legs syndrome |
126010931 | 12601093 | 7 | Breast cancer |
126010931 | 12601093 | 9 | Bone loss |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126010931 | 12601093 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126010931 | 12601093 | Alopecia | |
126010931 | 12601093 | Anxiety | |
126010931 | 12601093 | Appetite disorder | |
126010931 | 12601093 | Diarrhoea | |
126010931 | 12601093 | Dysgeusia | |
126010931 | 12601093 | Fatigue | |
126010931 | 12601093 | Feeding disorder | |
126010931 | 12601093 | Gastric disorder | |
126010931 | 12601093 | Irritable bowel syndrome | |
126010931 | 12601093 | Myalgia | |
126010931 | 12601093 | Photophobia | |
126010931 | 12601093 | Vision blurred | |
126010931 | 12601093 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126010931 | 12601093 | 1 | 2015 | 0 | ||
126010931 | 12601093 | 2 | 201512 | 0 | ||
126010931 | 12601093 | 3 | 2015 | 0 | ||
126010931 | 12601093 | 4 | 201512 | 201604 | 0 | |
126010931 | 12601093 | 5 | 201512 | 201604 | 0 | |
126010931 | 12601093 | 7 | 201605 | 0 | ||
126010931 | 12601093 | 9 | 201606 | 0 |